image
Larimar Therapeutics, Inc. LRMR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.93
-6.31 %
$ 124 M
Market Cap
-1.28
P/E
Price Target Average
780.83%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
33.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Larimar Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for LRMR of $17 , with forecasts ranging from a low of $14 to a high of $22 .
LRMR Lowest Price Target Wall Street Target
14 USD 625.39%
LRMR Average Price Target Wall Street Target
17 USD 780.83%
LRMR Highest Price Target Wall Street Target
22 USD 1039.90%
Price
Max Price Target
Min Price Target
Average Price Target
25252020151510105500Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart LRMR

image
$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart LRMR

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart LRMR

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)20232023202420242025202520262026202720272028202820292029